Fresenius Reports Record Home Dialysis Growth

In the 6 months since purchasing NxStage, Fresenius says that home dialysis growth is 8 times the rate of in-center HD, with more than 25,000 home dialysis patients.

Read the full article » | Posted 09-12-2019

Related Articles

• ETC Model Structure Did Not Move the Needle on Home Dialysis with Social Risk Factors Posted 07-12-2024
• FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death Posted 05-09-2024
• New Partnership Will Bring Tablo to 33 States Where US Renal Care has Clinics Posted 05-09-2024
• Tablo-maker Outset Joined the ANNA’s Partnership Advisory Council Posted 05-09-2024